James C. Foster - 15 Feb 2023 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Role
Chairman, President and CEO, Director
Signature
/s/ James C. Foster
Issuer symbol
CRL
Transactions as of
15 Feb 2023
Net transactions value
-$5,000,017
Form type
4
Filing time
17 Feb 2023, 15:02:24 UTC
Previous filing
31 Jan 2023
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRL Common Stock Sale $4,973,000 -19,892 -8.4% $250.00 216,702 15 Feb 2023 Direct F1, F2
transaction CRL Common Stock Sale $27,017 -108 -0.05% $250.16 216,594 15 Feb 2023 Direct F1, F2
holding CRL Common Stock 4,328 15 Feb 2023 2021 GRAT F2
holding CRL Common Stock 11,000 15 Feb 2023 2022 GRAT
holding CRL Common Stock 13,640 15 Feb 2023 2020 GRAT
holding CRL Common Stock 750 15 Feb 2023 By Trust
holding CRL Common Stock 340 15 Feb 2023 By Trust
holding CRL Common Stock 2,250 15 Feb 2023 By Trust
holding CRL Common Stock 10,000 15 Feb 2023 Held By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale occurred pursuant to a 10b5-1 Trading Plan.
F2 On 2/01/2023: 3,672 shares were transferred from the 2021 GRAT account to Direct Holdings.